| abstract |
A novel anti-human tenascin ST2146 monoclonal antibody with high affinity for native antigen and with high tumor selectivity is described. The cST2146 hybridoma stably produces antibodies under high-density culture conditions, and is suitable for industrial development of products based on ST2146. ST2146 exhibits properties that can be used for both therapeutic and diagnostic applications. |